Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
# 2 DOWN .40
IM HOLDING.. ..ONLY 3000 SHARES TRADED ...IT WILL GO BACK UP JUST AS FAST ........"I HOPE"......LOL
$9.59 FOR ME YESTERDAYS CHASE....
FUEL
ELN BREAKING OUT
ADSK
THANKS JOHN .I HAVE A BETTER UNDERSTANDING NOW ....BY THE WAY IM USED TO 2 AND 3 PERCENT LOSSES ALSO 10 AND 20 PERCENTERS ...LOL THATS WHY IM BLASHING NOW ......
JOHN ...ARE WE STILL IN #1 OR ARE WE OUT AT 4.50 ??? THANKS, JAKE
PPHM UP 21%....GOTTA LOVE IT .........LOL
PPHM MOVING UP ON NEWS
KEN .....PPHM TO THE MOON $$$$$$$$$
GOTTA GO .....EVERYBODY HAVE A GREAT WEEKEND....
BLASHER .
WHILE ITS TRUE I MADE SOME MONEY THE FIRST WEEK , I STILL BELIEVE IN THE OLD SAYING THAT EVEN A BLIND SQUIRREL FINDS A ACORN SOMETIMES.. TIME WILL TELL
EXAMPLE >> I ALWAYS TOLD MY WIFE NOT TO PLAY SLOTS IN ATLANTIC CITY .. STICK TO A TABLE GAME WHERE YOU AT LEAST HAVE TO MAKE A DECISION ..I THINK ITS A TOTAL WASTE OF MONEY ...SO AS I WAS WAITING FOR HER TO FINISH LOSING HER MONEY SO WE COULD GO TO DINNER , I PUT A DOLLAR IN THE MACHINE NEXT TO HER AND WON $15,000 ON MY FIRST PULL ...BLIND SQUIRREL THEORY ...ALSO IDIOT THEORY AS I NOW HAVE TO LISTEN TO HER TELL ME NOT TO PLAY BLACKJACK ANY MORE BECAUSE OF HOW GOOD I AM AT SLOTS .....
MY FIRST WEEK PRETTY GOOD TOO
#2 IN AT 1.70 OUT AT 1.73
#4 IN AT .96 OUT AT .93
# 5 IN AT 3.59 OUT AT 3.76
# 6 IN AT 9.50 OUT AT 10.04
I MISSED #7 AS IT RAN BEFORE I COULD GET IN AND # 8 WAS TOO EXPENSIVE FOR ME AT THIS TIME SINCE I HAVE A LOT OF MONEY TIED UP IN OTHER STOCKS ..PRE BLASHER...ALL IN ALL I HAD SOME FUN AND MADE A LITTLE EXTRA CASH ... I MET SOME GOOD PEOPLE ON THIS BOARD AND SO FAR IM A HAPPY CAMPER....JAKE
JOHN...ITS YOUR SHOW, ......YOU DO WHAT YOU FEEL IS BEST FOR EVERYONE.....
MELLO ..IM NOT TRYING TO CREATE WAVES JUST MAKE SOME MONEY LIKE EVERYONE ELSE ...I JUST STARTED FIGURING OUT WHAT THE HECK THIS WHOLE THING IS ALL ABOUT AND AS A "SENIOR CITIZEN" CHANGE FRIGGIN SCARES ME .....LOL
I GUESS WE SHOULD ASK JOHN'S GIRLFRIEND / WIFE , IF JOHN IS GETTING BURNED OUT ..NAW, HE'S TOO YOUNG FOR THAT
I STILL LIKE THE PRESENT SYSTEM..... FWIW
FWIW.....
I THINK THE PRESENT SYSTEM IS JUST FINE ..... I LOVE THE GUIDANCE
ME TOO ....ARE YOU IN # 6 ??
STOCK # 5 GETTING SOME LEGS ...IM STILL HOLDING AS I GOT IN AT 3.59
AND IF YOUR AUNT HAD BALLS , SHE WOULD BE YOUR UNCLE.......LOL
NEWS ON # 2 THIS MORNING
KEN / FLOTA ......
I KNOW IVE BEEN A PAIN IN THE A$$ ...BUT THANKS FOR YOUR PATIENCE AND HELP .......JAKE
ATTENTION........
YOU GUYS NEED A DRILL SARGEANT LIKE THE ONE IN FULL METAL JACKET .... THAT WILL STRAIGHTEN YOU UP IN A REAL HURRY ....LOL
KEN....WHAT DO YOU MEAN NEWS IS SUPPOSED TO COME OUT LATER ?? DO YOU MEAN TODAY ? OR AFTERHOURS ?
BLASHER....I HOPE I WASNT COMING THRU AS BEING ARGUMENTIVE AS I ONLY WANT TO DO WHAT I FEEL IS THE RIGHT WAY TO MAKE MONEY USING THE SYSTEM . SINCE IT IS MY FIRST WEEK , MAYBE I MIS-UNDERSTOOD BUT OF THE STOCKS PICKED I THOUGHT YOU WERE GOING TO SAY WHAT YOU THOUGHT WAS THE BEST TIME TO ENTER AND EXIT EACH PLAY ........SORT OF LIKE A TOUT WITH THE HORSES.....LOL
BLASHER ....THATS EXACTLY WHAT I WAS DOING , BUYING ONLY AFTER YOU SAID TO BUY AS PER YOUR MESSAGE # 1432 WHICH STATED "
Very Important ... the PowerScan© picks are BEST taken advantage of if you monitor this Message Board and get in and out in conjunction with our comments here.
However, if you can not monitor this Board during the day, I just want to caution that after a good run, it may, at some point later, NOT be a good idea to get into a PowerScan© pick
AM I MIS-UNDERSTANDING WHAT YOU MEAN ?? JAKE
PPHM MOVING NICE TODAY
BLASH ..UNLESS I MISSED SOMETHING YOU QUOTED "
- strong move today .. but all in the last 15-minutes, so we missed it
- probably going to be too volatile for us now ...
- but we will monitor and report
HOW AND WHEN DID WE GET INTO THIS ?
HERES THE WHOLE POST KEN
Journal of Clinical Oncology Publishes Significant Anti-Tumor Activity of
Tumor Necrosis Therapy for Treating Patients With Advanced Lung Cancer
TUSTIN, Calif., March 2 /PRNewswire-FirstCall/ -- Peregrine
Pharmaceuticals, Inc. (Nasdaq: PPHM) announced today the publication of data
in the Journal of Clinical Oncology demonstrating significant anti-tumor
activity in a study of 107 patients with advanced lung cancer treated at eight
oncology centers in China with an iodine-131 radiolabeled Tumor Necrosis
Therapy antibody (131I-TNT). In the published article, approximately 90% of
patients treated with 131I-TNT had stable disease or better with 3.7%
achieving complete responses, 30.8% achieving partial responses involving at
least 50% shrinkage of their tumors and 55.1% achieving stable disease
(representing no change in the tumor mass). The Objective Response Rate (ORR)
to the therapy was 34.6% as measured by World Health Organization criteria
(WHO).
According to the study, radioimmunotherapy with Iodine-131 chimeric TNT
was well tolerated and can be used intravenously or intratumorally to treat
refractory tumors of the lung. While the overall response rate in patients
treated intravenously and intratumorally were approximately 36% and 33%,
respectively, the severity of side effects related to the drug was lower in
patients treated intratumorally. ORR was defined according to WHO criteria
for measuring solid tumors as patients with a complete response defined as
disappearance of all known lesion(s), or partial response defined as at least
a 50% decrease; confirmed at four weeks.
"The publication of this data in the Journal of Clinical Oncology affirms
the TNT approach to treating lung cancer," said Steven King, president and CEO
of Peregrine. "The recent completion of enrollment in a Phase I safety study
using our similar product Cotara(R), along with this promising data in the
treatment of lung cancer, opens the possibility for similar trials in the
U.S."
"This compelling tumor response data in advanced lung cancer and the
clinical data we have generated in brain cancer demonstrate TNT's ability to
clinically benefit people suffering from cancer," stated Joe Shan, Director of
Clinical Development at Peregrine Pharmaceuticals. "We are looking forward to
initiating clinical enrollment in our brain cancer trial in collaboration with
the New Approaches to Brain Tumor Therapy consortium."
About Cotara(R) and Tumor Necrosis Therapy (TNT) Platform
The company is developing a radioactive chimeric TNT antibody that it has
trademarked Cotara(R) for the treatment of cancer. Cotara(R) is designed to
bind to the dead or dying tissue within the tumor and, once bound, its
radioisotope irradiates nearby cells resulting in the death of nearby tumor
cells.
Rapidly growing tumors quickly outgrow their blood supply resulting in a
region of tumor cells that do not receive adequate oxygen, nutrients and waste
removal. The accumulation of dying cells results in the formation of a dead,
or necrotic, core present in virtually all solid tumors beyond a very small
size. TNT-based products directly target and bind to dead and dying tumor
cells found in virtually all solid tumors. By using the necrotic core as a
stable anchorage in the heart of a tumor, TNT-based therapeutic agents have
the potential to deliver therapeutic agents preferentially targeted to
virtually all solid tumors, including brain, lung, colon, breast, liver,
prostate and pancreatic cancers.
The company is working with New Approaches to Brain Tumor Therapy (NABTT)
Consortium to initiate the first part of Peregrine's U.S. Food and Drug
Administration (FDA)-approved product registration trial using Cotara(R) to
treat patients with brain cancer. Peregrine has also completed enrollment in a
Phase I Cotara(R) clinical trial for the treatment of colorectal carcinoma at
Stanford University Medical Center and is working closely with scientific
advisors to design Phase II studies using Cotara(R) for other solid tumor
indications. In addition, a TNT-based agent similar to Cotara(R) was developed
under a licensing agreement in China and has received marketing approval for
the treatment of advanced lung cancer.
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals (Peregrine) is a biopharmaceutical company
primarily engaged in the research, development, manufacture and
commercialization of cancer therapeutics and diagnostics through a series of
proprietary platform technologies. The company is primarily focused on
discovering and developing products that affect blood vessels and blood flow
in cancer and other diseases. Peregrine's vascular research programs fall
under several different proprietary platforms, including Anti-Phospholipid
Therapy (APT), Vascular Targeting Agents (VTAs), Anti-Angiogenesis and
Vasopermeation Enhancement Agents (VEAs).
Peregrine recently received approval from the FDA for its Tarvacin(TM)
Phase I study for the treatment of cancer. Tarvacin(TM), a novel anti-cancer
agent, is part of Peregrine's Anti-Phospholipid Therapy (APT) platform, which
binds directly to tumor blood vessels to inhibit tumor growth and development.
The company plans on initiating the approved Phase I study in the near term.
For other recent news or additional information about the company, please
visit http://www.peregrineinc.com
PPHM NEWS
TUSTIN, Calif., March 2 /PRNewswire-FirstCall/ -- Peregrine
Pharmaceuticals, Inc. (Nasdaq: PPHM) announced today the publication of data
in the Journal of Clinical Oncology demonstrating significant anti-tumor
PPHM NEWS
TUSTIN, Calif., March 2 /PRNewswire-FirstCall/ -- Peregrine
Pharmaceuticals, Inc. (Nasdaq: PPHM) announced today the publication of data
in the Journal of Clinical Oncology demonstrating significant anti-tumor
VIGN ...
KEN...JUST OUT OF CURIOUSITY I TRIED TO GET A QUOTE FROM WATERHOUSE ON SOME OF THESE AND WASNT ABLE TO ...ALVG.DE AND CBKG.DE HOW WOULD WE GO ABOUT THIS ?? JAKE
IM BACKKKKK
KEN...I HAVENT TYPED BR IN THE CHART ...ALL I HAVE DONE IS COPY AND PASTE THE CHART AND THEN DELETE OR BACKSPACE ELN AND TYPE IN IESV AND HIT SUBMIT ... ,uu[w,a]daclyiay[dc][pc5!b10!d20,2][vc60][iut!lv22!lk14!ll14!lb14!lh9,3!lxa!la8,17,9!lm12!ld8!lya7,14,28!LI14,3!LE5,10,15][j20444984,y]&r=3555>
IESV BREAKING OUT
IESV FLYING RIGHT NOW ..CHART WONT POST FOR ME
,uu[w,a]daclyiay[dc][pc5!b10!d20,2][vc60][iut!lv22!lk14!ll14!lb14!lh9,3!lxa!la8,17,9!lm12!ld8!lya7,14,28!LI14,3!LE5,10,15][j20444984,y]&r=3555>